Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism

Sarah-Maria Fendt, Eric L. Bell, Mark A. Keibler, Shawn M. Davidson, Gregory J. Wirth, Brian Fiske, Jared R. Mayers, Matthias Schwab, Gary Bellinger, Alfredo Csibi, Akash Patnaik, Marie Jose Blouin, Lewis C. Cantley, Leonard Guarente, John Blenis, Michael N. Pollak, Aria F. Olumi, Matthew G. Vander Heiden, Gregory Stephanopoulos

Cancer Res (2013) 73 (14): 4429–4438.

https://doi.org/10.1158/0008-5472.CAN-13-0080

Published: 15 July 2013

View articletitled, Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism

Includes: Supplementary data

Journal Articles

Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.

Ge Rongbin, Zongwei Wang, Aria F. Olumi

Cancer Res (2013) 73 (8_Supplement): 4965.

https://doi.org/10.1158/1538-7445.AM2013-4965

Published: 15 April 2013

View articletitled, Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.

Journal Articles

Abstract 2976: Dynamic expression of 5-alpha reductase 2 in aging prostate is regulated by DNA methyltransferase 1.

Rongbin Ge, Zongwei Wang, Chin-Lee Wu, Shahin Tabatabaei, Aria F. Olumi

Cancer Res (2013) 73 (8_Supplement): 2976.

https://doi.org/10.1158/1538-7445.AM2013-2976

Published: 15 April 2013

View articletitled, Abstract 2976: Dynamic expression of 5-alpha reductase 2 in aging prostate is regulated by DNA methyltransferase 1.

Journal Articles

Abstract 3234: Metformin shifts prostate cancer metabolism towards a less malignant phenotype

Gregory J. Wirth*, Sarah-Maria Fendt*, Eric L. Bell, Mark A. Keibler, Gregory Stephanopoulos, Aria F. Olumi

Cancer Res (2012) 72 (8_Supplement): 3234.

https://doi.org/10.1158/1538-7445.AM2012-3234

Published: 15 April 2012

View articletitled, Abstract 3234: Metformin shifts prostate cancer metabolism towards a less malignant phenotype

Journal Articles

Abstract 2912: F-box protein 10: A novel NF-κB–dependent antiapoptotic protein regulates TRAIL-induced apoptosis

Rongbin Ge, Zongwei Wang, Qing Zeng, Xiaoyin Xu, Aria F. Olumi

Cancer Res (2010) 70 (8_Supplement): 2912.

https://doi.org/10.1158/1538-7445.AM10-2912

Published: 15 April 2010

View articletitled, Abstract 2912: F-box protein 10: A novel NF-κB–dependent antiapoptotic protein regulates TRAIL-induced apoptosis

Journal Articles

Abstract #4229: Androgen mediated FLIP expression in androgen-sensitive prostatic cancer cell LNCaP as a novel target for 2-Methoxyestradiol (2-ME₂) induced apoptosis

Manonmani Ganapathy, Jianping Xie, Heather Graham, Aria F Olumi, Rita Ghosh, Addanki P Kumar

Cancer Res (2009) 69 (9_Supplement): 4229.

Published: 01 May 2009

View articletitled, Abstract #4229: Androgen mediated FLIP expression in androgen-sensitive prostatic cancer cell LNCaP as a novel target for 2-Methoxyestradiol (2-ME2) induced apoptosis

Journal Articles

Transcriptional regulation of FLIP as a therapeutic target in prostate cancer

Manonmani Ganapathy, Rita Ghosh, Xiaoping Zhang, Aria F Olumi, Kumar Addanki Pratap

Cancer Res (2008) 68 (9_Supplement): 4424.

Published: 01 May 2008

View articletitled, Transcriptional regulation of FLIP as a therapeutic target in prostate cancer

Journal Articles

c-Fos as a Proapoptotic Agent in TRAIL-Induced Apoptosis in Prostate Cancer Cells

Xiaoping Zhang, Liang Zhang, Hongmei Yang, Xu Huang, Hasan Otu, Towia A. Libermann, William C. DeWolf, Roya Khosravi-Far, Aria F. Olumi

Cancer Res (2007) 67 (19): 9425–9434.

https://doi.org/10.1158/0008-5472.CAN-07-1310

Published: 01 October 2007

View articletitled, c-Fos as a Proapoptotic Agent in TRAIL-Induced Apoptosis in Prostate Cancer Cells

Includes: Supplementary data

Journal Articles

Anti-proliferative activity of 2-Methoxyestradiol (2-ME) in prostate cancer cells through induction of apoptosis

Manonmani Ganapathy, Xiaoping Zhang*, Aria F Olumi *, Rita Ghosh, A Pratap Kumar

Cancer Res (2007) 67 (9_Supplement): 3618.

Published: 01 May 2007

View articletitled, Anti-proliferative activity of 2-Methoxyestradiol (2-ME) in prostate cancer cells through induction of apoptosis

Journal Articles

MG-132 Sensitizes TRAIL-Resistant Prostate Cancer Cells by Activating c-Fos/c-Jun Heterodimers and Repressing c-FLIP(L)

Wenhua Li, Xiaoping Zhang, Aria F. Olumi

Cancer Res (2007) 67 (5): 2247–2255.

https://doi.org/10.1158/0008-5472.CAN-06-3793

Published: 01 March 2007

View articletitled, MG-132 Sensitizes TRAIL-Resistant Prostate Cancer Cells by Activating c-Fos/c-Jun Heterodimers and Repressing c-FLIP(L)

Journal Articles

c-Fos functions as a pro-apoptotic agent and represses expression of c-FLIP(L)

Xiaoping Zhang, Hongmei Yang, William C. Dewolf, Roya Khosravi-Far, Aria F. Olumi

Cancer Res (2006) 66 (8_Supplement): 1007.

Published: 15 April 2006

View articletitled, c-Fos functions as a pro-apoptotic agent and represses expression of c-FLIP(L)

Journal Articles

Differential sensitivity to TRAIL-induced or TNF-induced apoptosis is determined by NF-κB activation in prostate cancer cells

Xu Huang, Xiaoping Zhang, Aria F. Olumi

Cancer Res (2006) 66 (8_Supplement): 178.

Published: 15 April 2006

View articletitled, Differential sensitivity to TRAIL-induced or TNF-induced apoptosis is determined by NF-κB activation in prostate cancer cells

Journal Articles

Increased expression of C-FOS/AP-1 is required for prostate cancer cells to undergo trail mediated apoptosis

Xiaoping Zhang, Hongmei Yang, William C. Dewolf, Roya Khosravi-Far, Aria F. Olumi

Cancer Res (2005) 65 (9_Supplement): 631–632.

Published: 01 May 2005

View articletitled, Increased expression of C-FOS/AP-1 is required for prostate cancer cells to undergo trail mediated apoptosis

Journal Articles

Persistent c-FLIP(L) Expression Is Necessary and Sufficient to Maintain Resistance to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand–Mediated Apoptosis in Prostate Cancer

Xiaoping Zhang, Tai-Guang Jin, Hongmei Yang, William C. DeWolf, Roya Khosravi-Far, Aria F. Olumi

Cancer Res (2004) 64 (19): 7086–7091.

https://doi.org/10.1158/0008-5472.CAN-04-1498

Published: 01 October 2004

View articletitled, Persistent c-FLIP(L) Expression Is Necessary and Sufficient to Maintain Resistance to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand–Mediated Apoptosis in Prostate Cancer

Journal Articles

TRAIL mediated apoptosis is regulated by c-FLIP(L) in prostate cancer

Xiaoping Zhang, Tai-Guang Jin, Hongmei Yang, William C. Dewolf, Roya Khosravi-Far, Aria F. Olumi

Cancer Res (2004) 64 (7_Supplement): 1145–1146.

Published: 01 April 2004

View articletitled, TRAIL mediated apoptosis is regulated by c-FLIP(L) in prostate cancer

Journal Articles

Carcinoma-associated Fibroblasts Direct Tumor Progression of Initiated Human Prostatic Epithelium

Aria F. Olumi, Gary D. Grossfeld, Simon W. Hayward, Peter R. Carroll, Thea D. Tlsty, Gerald R. Cunha

Cancer Res (1999) 59 (19): 5002–5011.

Published: 01 October 1999

View articletitled, Carcinoma-associated Fibroblasts Direct Tumor Progression of Initiated Human Prostatic Epithelium

Journal Articles

A Novel Coculture Technique Demonstrates That Normal Human Prostatic Fibroblasts Contribute to Tumor Formation of LNCaP Cells by Retarding Cell Death

Aria F. Olumi, Paul Dazin, Thea D. Tlsty

Cancer Res (1998) 58 (20): 4525–4530.

Published: 01 October 1998

View articletitled, A Novel Coculture Technique Demonstrates That Normal Human Prostatic Fibroblasts Contribute to Tumor Formation of LNCaP Cells by Retarding Cell Death

Journal Articles

Role of Chromosome 9 in Human Bladder Cancer

Noriomi Miyao, Yvonne C. Tsai, Seth P. Lerner, Aria F. Olumi, Charles H. Spruck, III, Mirella Gonzalez-Zulueta, Peter W. Nichols, Donald G. Skinner, Peter A. Jones

Cancer Res (1993) 53 (17): 4066–4070.

Published: 01 September 1993

View articletitled, Role of Chromosome 9 in Human Bladder Cancer

Journal Articles

Distinct Pattern of p53 Mutations in Bladder Cancer: Relationship to Tobacco Usage

Charles H. Spruck, III, William M. Rideout, III, Aria F. Olumi, Petra F. Ohneseit, Allen S. Yang, Yvonne C. Tsai, Peter W. Nichols, Thomas Horn, Gregers G. Hermann, Kenneth Steven, Ronald K. Ross, Mimi C. Yu, Peter A. Jones

Cancer Res (1993) 53 (5): 1162–1166.

Published: 01 March 1993

View articletitled, Distinct Pattern of p53 Mutations in Bladder Cancer: Relationship to Tobacco Usage

Journal Articles

Allelic Loss of Chromosome 17p Distinguishes High Grade from Low Grade Transitional Cell Carcinomas of the Bladder

Aria F. Olumi, Yvonne C. Tsai, Peter W. Nichols, Donald G. Skinner, Delver R. Cain, Leon I. Bender, Peter A. Jones

Cancer Res (1990) 50 (21): 7081–7083.

Published: 01 November 1990

View articletitled, Allelic Loss of Chromosome 17p Distinguishes High Grade from Low Grade Transitional Cell Carcinomas of the Bladder

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism

Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.

Abstract 2976: Dynamic expression of 5-alpha reductase 2 in aging prostate is regulated by DNA methyltransferase 1.

Abstract 3234: Metformin shifts prostate cancer metabolism towards a less malignant phenotype

Abstract 2912: F-box protein 10: A novel NF-κB–dependent antiapoptotic protein regulates TRAIL-induced apoptosis

Abstract #4229: Androgen mediated FLIP expression in androgen-sensitive prostatic cancer cell LNCaP as a novel target for 2-Methoxyestradiol (2-ME₂) induced apoptosis

Transcriptional regulation of FLIP as a therapeutic target in prostate cancer

c-Fos as a Proapoptotic Agent in TRAIL-Induced Apoptosis in Prostate Cancer Cells

Anti-proliferative activity of 2-Methoxyestradiol (2-ME) in prostate cancer cells through induction of apoptosis

MG-132 Sensitizes TRAIL-Resistant Prostate Cancer Cells by Activating c-Fos/c-Jun Heterodimers and Repressing c-FLIP(L)

c-Fos functions as a pro-apoptotic agent and represses expression of c-FLIP(L)

Differential sensitivity to TRAIL-induced or TNF-induced apoptosis is determined by NF-κB activation in prostate cancer cells

Increased expression of C-FOS/AP-1 is required for prostate cancer cells to undergo trail mediated apoptosis

Persistent c-FLIP(L) Expression Is Necessary and Sufficient to Maintain Resistance to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand–Mediated Apoptosis in Prostate Cancer

TRAIL mediated apoptosis is regulated by c-FLIP(L) in prostate cancer

Carcinoma-associated Fibroblasts Direct Tumor Progression of Initiated Human Prostatic Epithelium

A Novel Coculture Technique Demonstrates That Normal Human Prostatic Fibroblasts Contribute to Tumor Formation of LNCaP Cells by Retarding Cell Death

Role of Chromosome 9 in Human Bladder Cancer

Distinct Pattern of p53 Mutations in Bladder Cancer: Relationship to Tobacco Usage

Allelic Loss of Chromosome 17p Distinguishes High Grade from Low Grade Transitional Cell Carcinomas of the Bladder

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only